Shalby Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)
Shalby Ltd · Outcome · 03 Nov 2026, 11:42 pm
Shalby Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 3,132 (+9.7% YoY | -5.4% QoQ) ■ EBITDA: 414 (-0.5% YoY | -0.5% QoQ) ■ EBITDA Margin (%): 13.2 (-136 bps YoY | +66 bps QoQ) ■ PAT: 82.8 (-1.3% YoY | -23.7% QoQ) ■ EPS (INR): 0.73 (+7.4% YoY | -25.5% QoQ) Shalby Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) Segmental Performance Healthcare Services ■ Revenue: 2,832 (+12.1% YoY | -1.9% QoQ) ■ EBIT: 281 (+9.8% YoY | -9.8% QoQ) ■ EBIT Margin (%): 9.9 (-21 bps YoY | -87 bps QoQ) Manufacturing & Trading of Implants ■ Revenue: 300 (-8.8% YoY | -29.3% QoQ) ■ EBIT: -116 (-78.5% YoY | -1.4% QoQ) ■ EBIT Margin (%): -38.8 (-1900 bps YoY | -1177 bps QoQ)
Original exchange filing (PDF)
More announcements from Shalby Ltd
- Earnings Call Transcript - conference call held on 04-Nov-2026 · 07 Nov 2026
- Disclosure under Regulation 30(5) of SEBI (LODR) Regulations · 05 Nov 2026
- Audio recording for earnings conference call for Q2 FY 2026-27 · 04 Nov 2026
- Investor Presentation for the quarter ended September 30, 2026 · 04 Nov 2026
- Appointment of Executive Director for a term of five years · 04 Nov 2026
- Financial Results for the quarter and half year ended September 30, 2026 · 04 Nov 2026
- Intimation u/r. 30 of SEBI LODR · 29 Oct 2026
- Schedule of Earnings Conference Call to discuss Q2FY2027 earnings · 04 Nov 2026
